Treatment of Cold Agglutinin Syndrome Secondary to Chronic Lymphocytic Leukemia With Sutimlimab and Obinutuzumab-Venetoclax. [PDF]
Lap CJ, Broome CM.
europepmc +1 more source
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley +1 more source
Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia. [PDF]
Chu CC +11 more
europepmc +1 more source
Chronic lymphocytic leukemia management in India: balancing evidence, access, and affordability in clinical practice. [PDF]
Sahni S, Rani L, Gupta R, Gogia A.
europepmc +1 more source
Case Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States. [PDF]
Persico M +5 more
europepmc +1 more source
Renal Involvement in Indolent and Aggressive B-Cell Neoplasms: A Comparative Study of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Diffuse Large B-Cell Lymphoma. [PDF]
Zhao Y +11 more
europepmc +1 more source
Related searches:
CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3
Leukemia and Lymphoma, 1991Daniel Catovsky, T J Hamblin
exaly
p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis
British Journal of Haematology, 1997Rifat A Hamoudi +2 more
exaly

